Biogen Inc. said it is too early to tell how a report from the Japanese Health Ministry on suicides among patients taking alpha interferon will affect its royalties from the drug, which is sold by Schering-Plough Corp.

According to the study disclosed last week, between July 1987 and December 1993, 32 patients on alpha interferon attempted suicide, 12 successfully.